Month: January 2025

Children who were severely ill with multisystem inflammatory syndrome in children (MIS-C) related to COVID-19 infection appear to show excellent cardiovascular and noncardiovascular outcomes by 6 months, according to data published in JAMA Pediatrics. MIS-C is a life-threatening complication of COVID-19 infection and data on outcomes are limited…Read More

The latest glucagon-like peptide 1 (GLP-1) receptor agonists have been heralded for their potential to not only boost weight loss and glucose control but also improve cardiovascular, gastric, hepatic, and renal values. Throughout 2024, research has also indicated GLP-1 drugs may reduce risks for obesity-related cancer as well…Read More

Riya Shah was unprepared. The fourth-year medical student at Wayne State University in Detroit already spent more than $2000 on her residency application and the additional costs just kept piling up: registration fees, transcript fees, away rotation applications.  She knew applying to residency was expensive, but no one made it clear just how much money […]

Older adults are living longer, but wait lists for services to support healthy aging in British Columbia (BC) have increased — sometimes dramatically — over the past 5 years, a new report revealed. The “Monitoring Seniors Services 2024” report, published online last month by BC’s Office of the Seniors Advocate…Read More

Perhaps you’ve dreamed of becoming a doctor for as long as you can remember. Now that you’re in medical school, the finish line is in sight. But what happens after you finally cross it and are a practicing doctor? What can you expect and how will the demands of healing others affect the rest of […]

Senior midwives and researchers with experience in criminal and social justice are among those calling for improved maternity provision for pregnant women in UK prisons…Read More

The UK needs an overarching national strategy to tackle alcohol-related harms, argue experts in The BMJ, as deaths from alcohol in England reach their highest level on record…Read More

A common antihistamine may offer hope for patients with a rare genetic disease that can lead to severe liver damage and ultimately require transplantation, according to new research from Rutgers Health…Read More

In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive disease by 46% and improved survival compared to trastuzumab alone, according to the final results of the Phase III KATHERINE clinical trial led by researchers from the University of Pittsburgh and UPMC […]

Histopathological evaluation of tumor specimens has long been essential in diagnosing breast cancer and guiding clinical decision-making. However, one of the key challenges in routine diagnostics includes the inter-observer and inter-lab variabilities present in the assessment of prognostic markers that could lead to under- and over-treatment of patients…Read More